Updated:
May 27, 2021 11:36 IST
Mohabbat Singh was administered a cocktail of Casirivimab and Imdevimab at the Medanta Hospital as part of the “single dose infusion-based treatment.”
Share Article
AAA
Mohabbat Singh was administered a cocktail of Casirivimab and Imdevimab at the Medanta Hospital as part of the “single dose infusion-based treatment.” An 84-year-old COVID-positive man who was given monoclonal antibody therapy in Gurgaon, which is said to reduce the chance of hospitalisation by 70% in patients with mild to moderate symptoms, is back to his home, hospital authorities said on Wednesday. Mohabbat Singh was administered a cocktail of Casirivimab and Imdevimab at the Medanta Hospital as part of the “single dose infusion-based treatment” on Tuesday and then kept under observation.
NEW DELHI: Mohabbat Singh, 84, from Haryana has become the first person in India to be administered the “famous” Covid drug cocktail given to former US president Donald Trump. Singh, who has been under treatment for the past five days, was given the drug over 30-minute intravenous supply on Tuesday at Medanta, Gurugram.
The drug, Regeneron, is touted as a breakthrough treatment for certain patients as it shortens symptom duration and reduces viral load by fast acting antibodies.
The first batch of the Roche drug with two antibodies Casirivimab and Imdevimab reached India on Monday. “This drug is different from convalescent plasma and entirely different from repurposed drugs like Remdesivir or Tocilizumab. Studies show that 80% of patients who took this drug didn’t need hospitalisation, and it also reduced death rate in addition to shortening the duration of symptoms,” Dr Naresh Trehan, director, Medanta, told TOI.
Gurugram (Haryana) [India], May 26 (ANI): An 84-year-old man from Haryana has become the first person in India to be administered the Covid drug cocktail, which came into limelight after it was administered to former US President Donald Trump when he tested positive for the virus last year.